GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Panacos Pharmaceuticals Inc (GREY:PANC) » Definitions » Cyclically Adjusted PB Ratio

PANC (Panacos Pharmaceuticals) Cyclically Adjusted PB Ratio : (As of Sep. 22, 2024)


View and export this data going back to 1998. Start your Free Trial

What is Panacos Pharmaceuticals Cyclically Adjusted PB Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


Panacos Pharmaceuticals Cyclically Adjusted PB Ratio Historical Data

The historical data trend for Panacos Pharmaceuticals's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Panacos Pharmaceuticals Cyclically Adjusted PB Ratio Chart

Panacos Pharmaceuticals Annual Data
Trend Dec98 Dec99 Dec00 Dec01 Dec02 Dec03 Dec04 Dec05 Dec06 Dec07
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Panacos Pharmaceuticals Quarterly Data
Dec03 Mar04 Jun04 Sep04 Dec04 Mar05 Jun05 Sep05 Dec05 Mar06 Jun06 Sep06 Dec06 Mar07 Jun07 Sep07 Dec07 Mar08 Jun08 Sep08
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Panacos Pharmaceuticals's Cyclically Adjusted PB Ratio

For the Biotechnology subindustry, Panacos Pharmaceuticals's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Panacos Pharmaceuticals's Cyclically Adjusted PB Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Panacos Pharmaceuticals's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Panacos Pharmaceuticals's Cyclically Adjusted PB Ratio falls into.



Panacos Pharmaceuticals Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

Panacos Pharmaceuticals's Cyclically Adjusted Book per Share for the quarter that ended in Sep. 2008 is calculated as:

For example, Panacos Pharmaceuticals's adjusted Book Value per Share data for the three months ended in Sep. 2008 was:

Adj_Book=Book Value per Share/CPI of Sep. 2008 (Change)*Current CPI (Sep. 2008)
=0.098/92.3069*92.3069
=0.098

Current CPI (Sep. 2008) = 92.3069.

Panacos Pharmaceuticals Quarterly Data

Book Value per Share CPI Adj_Book
199812 43.369 69.151 57.891
199903 43.826 69.615 58.111
199906 41.328 70.122 54.403
199909 25.387 70.839 33.081
199912 28.065 71.008 36.483
200003 27.944 72.231 35.711
200006 25.456 72.737 32.305
200009 22.999 73.286 28.968
200012 22.655 73.413 28.486
200103 22.634 74.341 28.104
200106 16.268 75.100 19.995
200109 15.258 75.227 18.722
200112 14.417 74.552 17.851
200203 12.714 75.438 15.557
200206 10.304 75.902 12.531
200209 7.679 76.366 9.282
200212 5.647 76.324 6.830
200303 2.857 77.716 3.393
200306 4.400 77.505 5.240
200309 2.769 78.138 3.271
200312 2.306 77.758 2.737
200403 2.906 79.066 3.393
200406 2.381 80.037 2.746
200409 1.733 80.121 1.997
200412 -4.855 80.290 -5.582
200503 3.442 81.555 3.896
200506 0.325 82.062 0.366
200509 0.210 83.876 0.231
200512 1.739 83.032 1.933
200603 1.598 84.298 1.750
200606 1.417 85.606 1.528
200609 1.281 85.606 1.381
200612 1.110 85.142 1.203
200703 0.944 86.640 1.006
200706 0.816 87.906 0.857
200709 0.693 87.964 0.727
200712 0.539 88.616 0.561
200803 0.401 90.090 0.411
200806 0.235 92.320 0.235
200809 0.098 92.307 0.098

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Panacos Pharmaceuticals  (GREY:PANC) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


Panacos Pharmaceuticals Cyclically Adjusted PB Ratio Related Terms

Thank you for viewing the detailed overview of Panacos Pharmaceuticals's Cyclically Adjusted PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Panacos Pharmaceuticals Business Description

Traded in Other Exchanges
N/A
Address
134 Coolidge Avenue, Watertown, MA, USA, 02472
Panacos Pharmaceuticals Inc is a biotechnology company that seeks to develop next generation anti-infective products through the discovery and development of small-molecule oral drugs designed to treat HIV and other human viral diseases.

Panacos Pharmaceuticals Headlines

No Headlines